Walvax Biotechnology Co., Ltd. (SHE: 300142)
China
· Delayed Price · Currency is CNY
15.96
+0.07 (0.44%)
Nov 15, 2024, 10:22 AM CST
Walvax Biotechnology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 3,623 | 4,365 | 3,873 | 3,443 | 1,962 | 2,381 | Upgrade
|
Cash & Short-Term Investments | 3,623 | 4,365 | 3,873 | 3,443 | 1,962 | 2,381 | Upgrade
|
Cash Growth | -11.35% | 12.68% | 12.49% | 75.54% | -17.62% | -4.15% | Upgrade
|
Accounts Receivable | 2,715 | 3,101 | 3,577 | 2,481 | 2,004 | 512.84 | Upgrade
|
Other Receivables | 81.02 | 166.15 | 416.13 | 774.86 | 304.77 | 217.19 | Upgrade
|
Receivables | 2,796 | 3,267 | 3,993 | 3,255 | 2,308 | 730.03 | Upgrade
|
Inventory | 908.62 | 1,035 | 995.81 | 873.59 | 483.56 | 313.05 | Upgrade
|
Other Current Assets | 70.19 | 67.24 | 86.25 | 107.94 | 26.77 | 19.41 | Upgrade
|
Total Current Assets | 7,398 | 8,733 | 8,948 | 7,680 | 4,780 | 3,444 | Upgrade
|
Property, Plant & Equipment | 4,005 | 3,768 | 3,161 | 2,604 | 1,590 | 1,389 | Upgrade
|
Long-Term Investments | 985.73 | 1,057 | 1,292 | 1,491 | 1,605 | 862.27 | Upgrade
|
Goodwill | 33.66 | 33.66 | 33.66 | 33.66 | 33.66 | 33.66 | Upgrade
|
Other Intangible Assets | 1,013 | 1,086 | 1,167 | 434.98 | 271.68 | 127.04 | Upgrade
|
Long-Term Deferred Tax Assets | 96.28 | 103.44 | 124.84 | 168.01 | 138.55 | 91.61 | Upgrade
|
Long-Term Deferred Charges | 507.18 | 473.48 | 309.38 | 1,022 | 890 | 883.92 | Upgrade
|
Other Long-Term Assets | 965.07 | 333.54 | 300.2 | 240.63 | 329.41 | 186.97 | Upgrade
|
Total Assets | 15,004 | 15,589 | 15,336 | 13,674 | 9,638 | 7,018 | Upgrade
|
Accounts Payable | 1,505 | 1,805 | 1,836 | 1,258 | 607.79 | 276.74 | Upgrade
|
Accrued Expenses | 29.82 | 776.63 | 1,189 | 754.71 | 497.41 | 45.88 | Upgrade
|
Short-Term Debt | 220.16 | 320.27 | 97.18 | 310 | 40 | - | Upgrade
|
Current Portion of Long-Term Debt | 42.49 | 8.79 | - | - | - | - | Upgrade
|
Current Portion of Leases | - | 21.88 | 23.35 | 4.6 | - | - | Upgrade
|
Current Income Taxes Payable | 13.63 | 14.13 | 19.47 | 2.03 | 68.54 | 32.97 | Upgrade
|
Current Unearned Revenue | 43.38 | 42.47 | 66.78 | 35.29 | 9.68 | - | Upgrade
|
Other Current Liabilities | 535.82 | 214.66 | 276.22 | 870.61 | 198.55 | 732.88 | Upgrade
|
Total Current Liabilities | 2,390 | 3,204 | 3,509 | 3,235 | 1,422 | 1,088 | Upgrade
|
Long-Term Debt | 449.31 | 434.9 | 314.24 | - | - | - | Upgrade
|
Long-Term Leases | 13.22 | 20.6 | 27.74 | 1.06 | - | - | Upgrade
|
Long-Term Unearned Revenue | 283.12 | 423.33 | 404.53 | 344.3 | 256.18 | 223.14 | Upgrade
|
Long-Term Deferred Tax Liabilities | 65.07 | 68.71 | 90.94 | 94.56 | 112.27 | 40.16 | Upgrade
|
Other Long-Term Liabilities | 73.03 | 42.08 | - | - | - | - | Upgrade
|
Total Liabilities | 3,274 | 4,194 | 4,346 | 3,675 | 1,790 | 1,352 | Upgrade
|
Common Stock | 1,599 | 1,607 | 1,607 | 1,601 | 1,546 | 1,537 | Upgrade
|
Additional Paid-In Capital | 4,549 | 4,900 | 4,965 | 4,772 | 3,262 | 2,755 | Upgrade
|
Retained Earnings | 3,224 | 2,984 | 2,580 | 1,895 | 1,546 | 573.19 | Upgrade
|
Treasury Stock | - | -358.63 | -286.42 | - | - | - | Upgrade
|
Comprehensive Income & Other | 217.18 | 217.18 | 217.18 | 216.33 | 190.88 | - | Upgrade
|
Total Common Equity | 9,590 | 9,349 | 9,084 | 8,484 | 6,545 | 4,865 | Upgrade
|
Minority Interest | 2,140 | 2,046 | 1,906 | 1,515 | 1,303 | 800.8 | Upgrade
|
Shareholders' Equity | 11,730 | 11,395 | 10,990 | 9,999 | 7,848 | 5,666 | Upgrade
|
Total Liabilities & Equity | 15,004 | 15,589 | 15,336 | 13,674 | 9,638 | 7,018 | Upgrade
|
Total Debt | 725.17 | 806.42 | 462.51 | 315.67 | 40 | - | Upgrade
|
Net Cash (Debt) | 2,898 | 3,558 | 3,411 | 3,128 | 1,922 | 2,381 | Upgrade
|
Net Cash Growth | -17.98% | 4.31% | 9.06% | 62.77% | -19.30% | 8.32% | Upgrade
|
Net Cash Per Share | 1.81 | 2.22 | 2.13 | 1.99 | 1.23 | 1.55 | Upgrade
|
Filing Date Shares Outstanding | 1,599 | 1,599 | 1,601 | 1,601 | 1,546 | 1,537 | Upgrade
|
Total Common Shares Outstanding | 1,599 | 1,599 | 1,601 | 1,601 | 1,546 | 1,537 | Upgrade
|
Working Capital | 5,008 | 5,529 | 5,440 | 4,445 | 3,358 | 2,355 | Upgrade
|
Book Value Per Share | 6.00 | 5.85 | 5.67 | 5.30 | 4.23 | 3.16 | Upgrade
|
Tangible Book Value | 8,543 | 8,230 | 7,883 | 8,016 | 6,239 | 4,704 | Upgrade
|
Tangible Book Value Per Share | 5.34 | 5.15 | 4.92 | 5.01 | 4.04 | 3.06 | Upgrade
|
Buildings | - | 948.5 | 767.91 | 541.68 | 487.84 | 461.58 | Upgrade
|
Machinery | - | 2,093 | 1,580 | 1,235 | 930.76 | 744.39 | Upgrade
|
Construction In Progress | - | 1,645 | 1,509 | 1,527 | 762.51 | 699.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.